Variant report
Variant | esv2763577 |
---|---|
Chromosome Location | chr2:49035249-49053711 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:48996460..48999048-chr2:49041792..49043593,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs62137365 | chr2:49035250-49035251 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550621261 | chr2:49035257-49035258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568873866 | chr2:49035271-49035272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533084162 | chr2:49035285-49035286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184132426 | chr2:49035289-49035290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145750271 | chr2:49035307-49035308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534212694 | chr2:49035317-49035318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555651862 | chr2:49035400-49035401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567803752 | chr2:49035468-49035469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10183851 | chr2:49035488-49035489 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs188894143 | chr2:49035502-49035503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62137366 | chr2:49035525-49035526 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs149210273 | chr2:49035554-49035555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113552397 | chr2:49035574-49035575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368494986 | chr2:49035637-49035638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572478325 | chr2:49035644-49035645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190975285 | chr2:49035662-49035663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561856202 | chr2:49035681-49035682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72884590 | chr2:49035692-49035693 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs75208241 | chr2:49035695-49035696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10183901 | chr2:49035714-49035715 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs532861301 | chr2:49035716-49035717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182737474 | chr2:49035724-49035725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545808476 | chr2:49035740-49035741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566092226 | chr2:49035828-49035829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557462258 | chr2:49035847-49035848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555310797 | chr2:49035865-49035866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368063654 | chr2:49035869-49035870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187014844 | chr2:49035900-49035901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34851917 | chr2:49035916-49035917 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs541331442 | chr2:49036024-49036025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567882941 | chr2:49036033-49036034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372645768 | chr2:49036046-49036047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538566485 | chr2:49036053-49036054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556474058 | chr2:49036085-49036086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571849757 | chr2:49036104-49036105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539093116 | chr2:49036217-49036218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs71407521 | chr2:49036226-49036227 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs143382027 | chr2:49036234-49036235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543059918 | chr2:49036243-49036244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549897164 | chr2:49036251-49036252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs59960946 | chr2:49036303-49036304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs369308786 | chr2:49036313-49036314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544542011 | chr2:49036319-49036320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191705644 | chr2:49036354-49036355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532971286 | chr2:49036372-49036373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544659612 | chr2:49036381-49036382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559839284 | chr2:49036393-49036394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs62137367 | chr2:49036411-49036412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527262878 | chr2:49036412-49036413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:48994600-49080200 | Weak transcription | Stomach Smooth Muscle | stomach |
2 | chr2:49027200-49037000 | Weak transcription | Ovary | ovary |
3 | chr2:49032800-49039000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr2:49037000-49037200 | Strong transcription | Ovary | ovary |
5 | chr2:49037200-49045400 | Weak transcription | Ovary | ovary |
6 | chr2:49038600-49039800 | Enhancers | Fetal Intestine Large | intestine |
7 | chr2:49039000-49040000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr2:49039200-49039800 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr2:49039200-49039800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr2:49039200-49040000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr2:49039200-49040400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr2:49039400-49039600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr2:49039800-49043600 | Weak transcription | Fetal Intestine Large | intestine |
14 | chr2:49040200-49040400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr2:49040400-49041200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
16 | chr2:49041200-49041400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr2:49042400-49042600 | Enhancers | Fetal Intestine Small | intestine |
18 | chr2:49042600-49043400 | Weak transcription | Fetal Intestine Small | intestine |
19 | chr2:49043400-49045600 | Enhancers | Fetal Intestine Small | intestine |
20 | chr2:49043600-49047000 | Enhancers | Fetal Intestine Large | intestine |
21 | chr2:49045400-49045800 | Enhancers | Ovary | ovary |
22 | chr2:49045800-49046000 | Weak transcription | Ovary | ovary |
23 | chr2:49046000-49046600 | Enhancers | Ovary | ovary |
24 | chr2:49046200-49047000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
25 | chr2:49046200-49047800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
26 | chr2:49046600-49053200 | Weak transcription | Ovary | ovary |